Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-IRBESARTAN HCTZ | 12.5MG 150MG | TABLET | Resolved | 2019-12-19 | 2021-09-10 | 101725 |
TEVA-TRIAMTERENE/HCTZ | 25MG 50MG | TABLET | Resolved | 2020-01-09 | 2020-02-13 | 102884 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2020-01-09 | 2020-06-25 | 102890 |
TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2020-01-09 | 2020-06-11 | 102898 |
TEVA-LEFLUNOMIDE | 10MG | TABLET | Resolved | 2020-01-09 | 2020-03-05 | 102901 |
TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2020-01-09 | 2020-03-05 | 102911 |
TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-01-09 | 2020-03-26 | 102917 |
TEVA-VARENICLINE | 1MG | TABLET | Resolved | 2020-01-09 | 2020-06-11 | 102926 |
TEVA-CANDESARTAN | 8MG | TABLET | Resolved | 2020-01-09 | 2020-08-21 | 102931 |
ACT MELOXICAM | 7.5MG | TABLET | Actual shortage | 2020-01-09 | 2020-01-09 | 102935 |
TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2020-01-17 | 2020-08-21 | 103510 |
TEVA-BROMAZEPAM | 3MG | TABLET | Resolved | 2020-01-17 | 2020-02-07 | 103552 |
TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2020-01-17 | 2020-04-02 | 103555 |
TEVA-BISOPROLOL | 5MG | TABLET | Resolved | 2020-01-17 | 2020-03-12 | 103558 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2020-01-17 | 2020-01-25 | 103561 |
TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-01-17 | 2020-01-30 | 103566 |
TEVA-ALENDRONATE | 70MG | TABLET | Resolved | 2020-01-17 | 2020-02-07 | 103569 |
TEVA-METFORMIN | 850MG | TABLET | Resolved | 2020-01-17 | 2020-10-22 | 103584 |
TEVA-RASAGILINE | 0.5MG | TABLET | Resolved | 2020-01-17 | 2020-06-04 | 103587 |
TEVA-RASAGILINE | 1MG | TABLET | Resolved | 2020-01-17 | 2020-06-18 | 103590 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
TEVA-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103791 |
TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |